Lv3
230 积分 2023-12-27 加入
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
25天前
已完结
EGFR-targeting ADCs: From oncogene addiction to antigen-guided drug delivery
25天前
已完结
The first ADC bearing the ferroptosis inducer RSL3 as a payload with conservation of the fragile electrophilic warhead
3个月前
已完结
Scribble deficiency mediates colon inflammation by inhibiting autophagy-dependent oxidative stress elimination
3个月前
已完结
Co-Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver-Chip for the Study of Drug-Induced Liver Injury
3个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
4个月前
已完结
Bridging membrane and cytoskeleton dynamics in the secretory and endocytic pathways
5个月前
已完结
SGN-B6A: A New Vedotin Antibody–Drug Conjugate Directed to Integrin Beta-6 for Multiple Carcinoma Indications
8个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
9个月前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
10个月前
已完结
皖公网安备34019202002308
